Dawn Svoronos - Net Worth and Insider Trading
Dawn Svoronos Net Worth
The estimated net worth of Dawn Svoronos is at least $4 Million dollars as of 2024-12-26. Dawn Svoronos is the Director of Medivation Inc and owns about 18,234 shares of Medivation Inc (MDVN) stock worth over $1 Million. Dawn Svoronos is the Director of PTC Therapeutics Inc and owns about 29,017 shares of PTC Therapeutics Inc (PTCT) stock worth over $1 Million. Dawn Svoronos is also the Director of Xenon Pharmaceuticals Inc and owns about 25,000 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $987,000. Besides these, Dawn Svoronos also holds Global Blood Therapeutics Inc (GBT) , Acelyrin Inc (SLRN) , Adverum Biotechnologies Inc (ADVM) . Details can be seen in Dawn Svoronos's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dawn Svoronos has not made any transactions after 2023-08-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dawn Svoronos
Dawn Svoronos Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dawn Svoronos owns 7 companies in total, including Global Blood Therapeutics Inc (GBT) , PTC Therapeutics Inc (PTCT) , and Xenon Pharmaceuticals Inc (XENE) among others .
Click here to see the complete history of Dawn Svoronos’s form 4 insider trades.
Insider Ownership Summary of Dawn Svoronos
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GBT | Global Blood Therapeutics Inc | 2022-06-21 | director |
| PTCT | PTC Therapeutics Inc | 2022-06-09 | director |
| XENE | Xenon Pharmaceuticals Inc | 2023-08-24 | director |
 | | 2018-12-21 | director |
| | 2016-09-28 | director |
| | 2022-05-16 | director |
| | 2023-05-09 | director |
Dawn Svoronos Latest Holdings Summary
Dawn Svoronos currently owns a total of 6 stocks. Among these stocks, Dawn Svoronos owns 18,234 shares of Medivation Inc (MDVN) as of March 14, 2016, with a value of $1 Million and a weighting of 34.98%. Dawn Svoronos owns 29,017 shares of PTC Therapeutics Inc (PTCT) as of June 9, 2022, with a value of $1 Million and a weighting of 31.33%. Dawn Svoronos also owns 25,000 shares of Xenon Pharmaceuticals Inc (XENE) as of August 24, 2023, with a value of $987,000 and a weighting of 23.25%. The other 3 stocks Global Blood Therapeutics Inc (GBT) , Acelyrin Inc (SLRN) , Adverum Biotechnologies Inc (ADVM) have a combined weighting of 10.44% among all his current holdings.
Latest Holdings of Dawn Svoronos
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MDVN | Medivation Inc | 2016-03-14 | 18,234 | 81.44 | 1,484,977 |
| PTCT | PTC Therapeutics Inc | 2022-06-09 | 29,017 | 45.84 | 1,330,139 |
| XENE | Xenon Pharmaceuticals Inc | 2023-08-24 | 25,000 | 39.48 | 987,000 |
| GBT | Global Blood Therapeutics Inc | 2022-06-21 | 5,376 | 68.49 | 368,202 |
| SLRN | Acelyrin Inc | 2023-05-09 | 15,000 | 3.32 | 49,800 |
| ADVM | Adverum Biotechnologies Inc | 2022-05-16 | 5,000 | 5.02 | 25,100 |
Holding Weightings of Dawn Svoronos
Dawn Svoronos Form 4 Trading Tracker
According to the SEC Form 4 filings, Dawn Svoronos has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 6,000 shares on March 14, 2016, which brought Dawn Svoronos around $233,400.
According to the SEC Form 4 filings, Dawn Svoronos has made a total of 5 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in PTC Therapeutics Inc is the sale of 738 shares on June 9, 2022, which brought Dawn Svoronos around $20,074.
According to the SEC Form 4 filings, Dawn Svoronos has made a total of 1 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 25,000 shares on August 24, 2023, which brought Dawn Svoronos around $967,500.
More details on Dawn Svoronos's insider transactions can be found in the Insider Trading History of Dawn Svoronos table.Insider Trading History of Dawn Svoronos
- 1
Dawn Svoronos Trading Performance
GuruFocus tracks the stock performance after each of Dawn Svoronos's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dawn Svoronos is 7.43%. GuruFocus also compares Dawn Svoronos's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dawn Svoronos within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dawn Svoronos's insider trading performs compared to the benchmark.
Performance of Dawn Svoronos
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.11 | | | | | |
| Relative Return to S&P 500(%) | -1.9 | | | | | |
Dawn Svoronos Ownership Network
Dawn Svoronos Owned Company Details
What does Global Blood Therapeutics Inc do?
Who are the key executives at Global Blood Therapeutics Inc?
Dawn Svoronos is the director of Global Blood Therapeutics Inc. Other key executives at Global Blood Therapeutics Inc include Chief Financial Officer Jeffrey S Farrow , See Remarks Nazila Habibizad , and Chief Human Resources Officer Carrie Krehlik .
Global Blood Therapeutics Inc (GBT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Global Blood Therapeutics Inc Insider Transactions
Dawn Svoronos Mailing Address
Above is the net worth, insider trading, and ownership report for Dawn Svoronos. You might contact Dawn Svoronos via mailing address: C/o Medivation, Inc., 525 Market St., 36th Floor, San Francisco Ca 94105.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
